[Inhibitory effect of phenazepam on protein and RNA catabolism in the supraoptic nucleus during REM-sleep deprivation].
D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000494:pharmacology*; D006651:Histocytochemistry; D007031:Hypothalamus / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D012313:RNA / Q000378:metabolism*; D051381:Rats; D012892:Sleep Deprivation; D012895:Sleep, REM; D013495:Supraoptic Nucleus / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D009419:Nerve Tissue Proteins; D001569:Benzodiazepines; C017928:phenazepam; D012313:RNA
Tormoziashchee vliianie fenazepama na katabolizm belkov i RNK v supraopticheskom iadre pri lishenii paradoksal'noĭ fazy sna.